Business Weekly TVs Ellee Seymour talks to Eben Upton, founder of Raspberry Pi.

Raspberry Pi is a credit-card sized computer that plugs into your TV and a keyboard. Founder Eben Upton hopes it inspires future generations of engineers.

Billy Boyle - 2Cs Communications interviews Owlstone co-founder Billy Boyle for Business Weekly TV. Billy Boyle and colleagues suspended their PhDs to form Owlstone Nanotech and launch a dime-sized sensor.

Product development and engineering consultancy, eg technology, is celebrating its 10 year anniversary in April. eg technology offers product design and development services to the medical, biotech and consumer sectors with a strong track-record of developing medical devices with CE and FDA approval.

Polatis is the world leader in optical switching technology innovations. Founded in 2005 as the merger of leading optical technology companies from Cambridge Massachusetts and Cambridge UK, Polatis combined products, technologies and resources to create new solutions for modern fibre-based networks.

Eight19 takes its name from the time it takes sunlight to reach the earth - eight minutes and 19 seconds. It’s mission is to develop the technologies and manufacturing processes that will bring off-grid solar power to a new generation of users, transforming lives and accelerating economic development.

Dawson King is CEO of pioneering healthcare startup, Cambridge Healthcare Ltd. The company is working in partnership with the NHS and Connecting for Health to develop howareyou.com, an e-Health portal for patients and healthcare professionals. The portal will integrate with the NHS IT infrastructure and provide the platform for an unlimited number of healthcare applications.

Liz Basing's Civil Service career has spanned a range of HQ and regional roles, all with a business focus and including industry sponsorship, economic intelligence, grant appraisal on both national and European schemes and a stint in the then DTI strategy unit.

With major research sites in Cambridge UK and Vienna in Austria, F-star is leading the development of the next generation of therapeutic antibodies and antibody fragments based on its unique Modular Antibody Technology.